placebo drug: Clinical Trials

15 trials of placebo drug, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 not yet recruiting, 2 recruiting, 2 withdrawn. 15 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 215Completed 6, Not yet recruiting 3, Recruiting 2, Withdrawn 2, Active not recruiting 1, Unknown 1
Phase 33Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 11Completed 1

Follow placebo drug: new trials by email Literature Review of placebo drug trials Research Report on placebo drug

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Choline and Iron Deficiency
choline bitartrate, placebo drug - Pediatric Iron Deficiency, Anemia
Phase 2 / Phase 3RecruitingUniversity of Minnesota3002025-08-112026-08-05
Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.
The test product is a ready-to-use sinbiotic preparation of multispecies probiotics, ca-butyrate and FOS, Placebo Drug - MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), Diabetes Mellitus
Phase 2Not yet recruitingEva Cubric1142025-07-012025-06-18
Phase IIa Trial of Oral SSS17 for Post-Arthroplasty Anemia
SSS17 Capsule (6 Dose Levels), Placebo Drug - Postoperative Anemia, Arthroplasty, Replacement, Hip
Phase 2Not yet recruitingShenyang Sunshine Pharmaceutical Co., LTD.902025-07-012025-06-11
Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981
CKD-981(1), CKD-981(2), Sham device - Knee Osteoarthritis
Phase 2CompletedChong Kun Dang Pharmaceutical1002025-04-282026-04-13
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
LHP588, Placebo Drug - Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
Phase 2RecruitingLighthouse Pharmaceuticals, Inc.3002025-02-172026-10-07
Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy
melatonin 3mg, Placebo Drug - Central Serous Chorioretinopathy, Melatonin
Phase 2 / Phase 3Not yet recruitingMohsen Pourazizi482025-02-012025-02-05
Efficacy of Locally Delivered Rosemary Extract Gel in Management of Periodontitis
Herbal therapy, Placebo Drug - Periodontitis (Stage 3), Periodontal Pocket
Phase 2CompletedAin Shams University482024-10-202026-04-13
The Therapeutic Effects of Bu Shen Yi Jing Pill on Semen Quality in Sub Fertile Males: a Randomized Controlled Trial
Bu Shen Yi Jing Pill, Placebo Drug - Male Infertility, Infertility
Phase 2Active not recruitingKK Women's and Children's Hospital592022-01-072024-10-10
Trial Comparing Preoperative Dienogest Therapy Followed by Surgery vs. Upfront Surgery to Save Ovarian Reserve in Young Women With Ovarian Endometrioma
Dienogest, Placebo drug, Surgery - Ovarian Reserve, Endometriosis
Phase 2WithdrawnSeoul National University Hospital2017-10-012017-10-31
Use of Sildenafil Citrate in Management of Mild Pre-eclampsia
Sildenafil 20 MG, Placebo Oral Tablet - Pre-Eclampsia; Mild
Phase 2 / Phase 3UnknownAssiut University802016-09-152017-08-28
A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder
Oxytocin, Social Skills focused CBT, Stress management/relaxation training - Autism Spectrum Disorders
Phase 2CompletedMassachusetts General Hospital922014-04-012020-01-27
Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients
Apixaban, Placebo drug - Venous Thromboembolism, Cancer
Phase 2CompletedOttawa Hospital Research Institute5752014-03-242018-11-20
HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone
Acyline, placebo hCG (no active ingredient), hCG (human chorionic gonadotropin) - Healthy Males
Phase 1 / Phase 2CompletedUniversity of Washington592009-03-012016-01-11
Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease
Polypill, Placebo drug - Cardiovascular Disease, Hypertension
Phase 2CompletedTehran University of Medical Sciences4752006-11-012009-10-02
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
Test Drug, Placebo Drug - Heroin Dependence, Opioid-Related Disorders
Phase 2WithdrawnUniversity of Colorado, Denver2002-12-012017-05-04

Conditions studied

Diabetes Mellitus (2)  ·  Hyperlipidemias (2)  ·  Hypertension (2)  ·  Alzheimer Disease (1)  ·  Anemia (1)  ·  Autism Spectrum Disorder (1)  ·  Cardiovascular Diseases (1)  ·  Central Serous Chorioretinopathy (1)  ·  Endometriosis (1)  ·  Heart Diseases (1)  ·  Heroin Dependence (1)  ·  Infertility (1)  ·  Infertility, Male (1)  ·  Iron Deficiencies (1)  ·  Lymphoma, Follicular (1)

Sponsors

Ain Shams University (1)  ·  Assiut University (1)  ·  Chong Kun Dang Pharmaceutical (1)  ·  Eva Cubric (1)  ·  KK Women's and Children's Hospital (1)  ·  Lighthouse Pharmaceuticals, Inc. (1)  ·  Massachusetts General Hospital (1)  ·  Mohsen Pourazizi (1)  ·  Ottawa Hospital Research Institute (1)  ·  Seoul National University Hospital (1)  ·  Shenyang Sunshine Pharmaceutical Co., LTD. (1)  ·  Tehran University of Medical Sciences (1)  ·  University of Colorado, Denver (1)  ·  University of Minnesota (1)  ·  University of Washington (1)

Countries

United States (5)  ·  Egypt (2)  ·  South Korea (2)  ·  Canada (1)  ·  China (1)  ·  Croatia (1)  ·  Iran (1)  ·  Singapore (1)

Top investigators

Akram Pourshams, PhD (1)  ·  Aude Henin, PhD (1)  ·  Fady Abdallah (1)  ·  Fatemeh Malekzadeh, M.D. (1)  ·  Hasan Kamel (1)  ·  Hisham Abou-Taleb (1)  ·  John Gabrieli, PhD (1)  ·  Kar K Cheng, PhD (1)  ·  Leslie Amass, Ph.D. (1)  ·  Mansoor Rastegarpanah, Ph.D. (1)  ·  Marc Carrier, MD (1)  ·  Marko Skelin, ass.prof.dr.sc, mag.pharm. (1)  ·  Mohsen Pourazizi (1)  ·  Phil Wells, MD (1)

Results publications

PMID 15507947, PMID 15713717, PMID 20484472, PMID 21374750, PMID 23040523, PMID 23798922, PMID 27400005, PMID 29557414, PMID 30511879, PMID 33337539, PMID 33857789, PMID 34622445, PMID 35124234, PMID 35660801, PMID 37811711, PMID 41257751, PMID 7504210, PMID 8623789, PMID 9819872

NIH funding

R01DA011160 (1), U54HD012629 (1)